m+Medelevator.RU
← Поиск публикаций
Frontiers in chemistry · 2026

Integrated in vivo and in silico validation of Corchorus olitorius seed-mediated cardioprotection against doxorubicin-induced cardiotoxicity via network pharmacology, molecular docking, and molecular dynamics.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Abd El-Mordy Fatma Mohamed, Maher Sherif A, Tammam Omar Y, Elrehany Mahmoud A, Hisham Mohamed, Rofaeil Remon R, Rateb Mostafa E, Oraby Hesham F, Ibrahim Mahmoud A A, Shawky Ahmed M, Bringmann Gerhard, Abdelmohsen Usama Ramadan, Shady Nourhan Hisham

Аннотация

BACKGROUND: Corchorus olitorius L., known in Arab countries as molokhia, is a leafy plant rich in many carotenoids, minerals, and vitamins; its seeds are also reported to offer cardioprotective effects. Although the cardioprotective effects of molokhia are ascribed to the presence of cardiac glycoside compounds, the exact action mechanisms remain uninvestigated.

METHODS: In this study, we examined the potential of molokhia seeds to protect against cardiopathy by isolating the major constituents of C. olitorius seeds, analyzing its gene expression in vivo, and conducting computational studies to demonstrate the cardioprotective activities of these constituents.

RESULTS: Crude extracts of C. olitorius seeds were found to reduce the expression of IL-1β, IL-6, TNF-α, NF-κB, ICAM-1, and MMP-9 that had increased upon the administration of doxorubicin (DOX). Electrocardiographic studies showed reduced heart rate along with prolongation of the PR interval, QRS complex, and ST segment upon Corchorus administration.

CONCLUSION: The findings of this study demonstrate that the cardioprotective effects of molokhia seeds against DOX-induced cardiotoxicity are probably mediated via anti-inflammatory actions.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты